Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets

Por: Pessoa J., Martins M., Casimiro S., Pérez-Plasencia C., Shoshan-Barmatz V.

---

Publicada: 1 ene 2022

---

---

Filiaciones:
Pessoa J.:
 CNC – Center for Neuroscience and Cell Biology, CIBB – Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal

Martins M.:
 Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Casimiro S.:
 Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Pérez-Plasencia C.:
 Laboratorio de Genómica, Unidad de Investigación Biomédica en Cáncer, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Instituto Nacional de Cancerología (INCAN), Mexico City, Mexico

Shoshan-Barmatz V.:
 Department of Life Sciences, National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, Israel